February 02, 2026 -- QDX’s quantum-powered software Rush is deployed on the National Computational Infrastructure’s (NCI) Gadi supercomputer, bringing cutting-edge quantum chemistry capabilities to researchers across Australia. The collaboration expands national access to advanced quantum chemistry tools for molecular modelling, drug discovery, and materials science.

This arrangement is under a Master Services Agreement signed between the Australian National University through the National Computational Infrastructure (NCI) and QDX Technologies Pty. Ltd.

QDX, co-founded by ANU alumnus Loong Wang and renowned computational chemist Professor Giuseppe Barca, has developed high-accuracy quantum mechanical simulations that replicate the behaviour of atoms, molecules, and chemical reactions. By combining the precision of quantum chemistry with the scale of high-performance computing, the company’s technology is already being applied to accelerate the discovery of new therapeutics.

“Deploying Rush on Gadi will allow Australian researchers to perform large-scale, high-accuracy quantum chemical calculations faster than ever before,” said Professor Barca. “This brings us closer to simulating complex biological systems at an unprecedented scale.”

By leveraging Gadi, researchers can use QDX’s proprietary algorithms to explore complex chemical and biological systems with greater accuracy and efficiency. The platform supports demanding quantum chemistry workloads, including enzyme active-site simulations, reaction mechanism modelling, molecular property prediction, and highly correlated electronic-structure calculations, without the time and cost constraints of traditional laboratory experimentation.

“This collaboration highlights how national research infrastructure supports innovation across academia and industry,” said NCI Director Professor Andrew Rohl. “We’re proud to provide a platform where tools like Rush can be deployed for the benefit of Australian researchers and accelerate discovery across scientific domains.”

A key outcome of the deployment is the democratisation of advanced quantum simulation tools. By hosting Rush on NCI, traditional barriers such as specialised hardware requirements, complex software installation, and high licensing costs are reduced. This ensures early-career researchers, small laboratories, and regional universities can access the same world-class capabilities used by global industry leaders.

With offices in Canberra, Melbourne, and Singapore, QDX partners with pharmaceutical and technology companies worldwide. The deployment of Rush on NCI marks a significant step toward empowering Australian researchers with next-generation computational tools, fuelling innovation across quantum chemistry, life sciences, and materials engineering.